Daily Stock Analysis, SVXY, Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California., priceseries

Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.. Daily Stock Analysis
Stock Information
Open
48.72
Close
46.70
High
48.77
Low
46.86
Previous Close
48.80
Daily Price Gain
-2.10
YTD High
63.40
YTD High Date
Jan 12, 2022
YTD Low
46.86
YTD Low Date
Mar 7, 2022
YTD Price Change
-15.87
YTD Gain
-25.36%
52 Week High
64.45
52 Week High Date
Nov 4, 2021
52 Week Low
40.80
52 Week Low Date
Mar 8, 2021
52 Week Price Change
5.38
52 Week Gain
13.02%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 3. 2017
194.90
Feb 16. 2017
248.65
31 Trading Days
27.58%
Link
LONG
Apr 24. 2017
283.34
May 17. 2017
299.68
17 Trading Days
5.77%
Link
LONG
Jul 10. 2017
320.34
Jul 27. 2017
353.07
13 Trading Days
10.22%
Link
LONG
Sep 11. 2017
322.76
Oct 24. 2017
416.54
31 Trading Days
29.05%
Link
LONG
Dec 7. 2017
459.56
Jan 16. 2018
537.37
25 Trading Days
16.93%
Link
LONG
May 4. 2018
50.12
May 29. 2018
52.85
16 Trading Days
5.44%
Link
LONG
Jan 4. 2019
43.66
Jan 22. 2019
46.00
11 Trading Days
5.36%
Link
LONG
Jun 28. 2019
53.87
Jul 19. 2019
56.62
14 Trading Days
5.10%
Link
LONG
Oct 11. 2019
53.82
Nov 20. 2019
59.89
28 Trading Days
11.27%
Link
LONG
Nov 4. 2020
36.54
Dec 10. 2020
41.18
25 Trading Days
12.69%
Link
LONG
May 21. 2021
49.00
Jun 18. 2021
52.71
19 Trading Days
7.57%
Link
LONG
Oct 7. 2021
56.98
Nov 5. 2021
62.32
21 Trading Days
9.37%
Link
Company Information
Stock Symbol
SVXY
Exchange
NASDAQ
Company URL
http://www.masttherapeutics.com
Company Phone
512-614-1848
CEO
Brian M. Culley
Headquarters
Texas
Business Address
900 S. CAPITAL OF TEXAS HIGHWAY, SUITE 150, AUSTIN, TX 78746
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001160308
About

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Description

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. Its lead product candidate is AIR001, a sodium nitrite solution for inhalation through nebulization, which is in Phase II clinical stage for the treatment of heart failure with preserved ejection fraction, as well as in Phase I/II study in patients with cystic fibrosis. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.